Abstract
Flavones are a new type of inhibitor of NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase, EC 1.6.99.2). To further characterize the flavone binding site, three bromoacetyl derivatives of flavones, i.e., 7-bromoacetylflavone, 5-hydroxyl-7-bromoacetylflavone, and 7,8-dibromoacetylflavone, have been synthesized. These compounds have been found to be potent inhibitors that inactivate the rat quinone reductase in a time-dependent manner, suggesting that they can be used as affinity labels for the enzyme. Among the three bromoacetyl derivatives, 7,8-dibromoacetylflavone is the most potent inhibitor; however, its labeling of the quinone reductase is the least stable, so that the enzyme regains activity after a short incubation. In contrast, the inactivation of the quinone reductase by 5-hydroxyl-7-bromoacetylflavone is stable. Accordingly, this flavone derivative is the most suitable compound for labeling the flavone binding site of the enzyme. Electrospray mass spectrometry has been applied to demonstrate that 5-hydroxyl-7-bromoacetylflavone labels this enzyme in a stoichiometric manner.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|